权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Effects of glycomacropeptide on memory and Alzheimer-related neuropathology

糖巨肽对记忆和阿尔茨海默相关神经病理学的影响

基本信息

批准号：
9898205
负责人：
MICHAEL P MCDONALD
金额：
$ 38万
依托单位：
UNIVERSITY OF TENNESSEE HEALTH SCI CTR
依托单位国家：
美国
项目类别：
财政年份：
2017
资助国家：
美国
起止时间：
2017-04-01 至 2022-03-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9898205
关键词：
Affective Age Age-Months Alzheimer associated neurodegeneration Alzheimer&apos s Disease Alzheimer&apos s disease model Alzheimer&apos s disease patient Alzheimer&apos s disease therapy Amyloid Amyloid beta-Protein Anxiety Attenuated Barbering Behavior Behavioral Binding Biological Brain Breast Feeding Cell Death Characteristics Charge Child Cognition Cognitive deficits Diet Disease Drug Design Evaluation Event Exhibits Fatty acid glycerol esters Ganglioside GM1 Goals Histologic Human Milk Impaired cognition Impairment Infant Interneurons Intervention Ion Exchange Ion-Exchange Chromatography Procedure Laboratory mice Lactose Learning Mediator of activation protein Membrane Proteins Memory Memory Loss Memory impairment Milk Mus National Institute of Neurological Disorders and Stroke National Institute on Aging Nerve Degeneration Neural Cell Adhesion Molecules Neurobehavioral Manifestations Neurofibrillary Tangles Neuroprotective Agents Oxidative Stress Partner in relationship Pathogenicity Pathology Pharmaceutical Preparations Positioning Attribute Process Proteins Publishing Quality of life Reporting Research Sialic Acids Social Behavior Source Supplementation Testing Therapeutic Therapeutic Effect Time Transgenic Mice Transgenic Organisms Vibrissae Whey Protein Wild Type Mouse abeta accumulation aged arm base behavioral impairment cholinergic cognitive enhancement cognitive function cognitive performance drinking water drug development experience experimental study habituation improved mouse model neurochemistry neuroinflammation neuron loss neuropathology neurotoxicity new therapeutic target novel overexpression patient subsets preservation prevent reduce symptoms success treatment strategy

项目摘要

A valid assessment of memory is perhaps the most important component of an endeavor to develop a novel treatment for Alzheimer's disease. However, memory is only one of the behavioral impairments that Alzheimer's patients exhibit. They also have affective and sensorimotor deficits, and problems with social behavior. Unlike other APP-overexpressing mice, the 5xFAD transgenics exhibit robust neurodegeneration by 9 months of age. Like other Alzheimer models, they exhibit profound cognitive deficits on tests of spatial learning and memory. However, the 5xFAD mice show a host of other behavioral anomalies. For example, they exhibit much more social behavior toward their cage-mates as do wild-type mice, but do not exhibit the barbering phenomenon characteristic of some strains of laboratory mice, including wild-types of the same strain. Although published reports show that 5xFAD mice spend more time on open arms of a plus maze, indicative of decreased anxiety, we have shown that this is attributable to impaired habituation and degeneration of inhibitory interneurons in layer IV whisker barrels (i.e., making closed arms aversive). We have shown previously that supplementing the diet with glycomacropeptide (GMP) reduces Aβ and neuroinflammation, and improves memory in 5xFAD transgenics. The active ingredient in GMP is sialic acid, a critical mediator of Aβ binding that has been shown to improve memory in piglets when added to their milk. A number of studies have shown that the cognitive performance of children who were breast-fed as infants is superior to that of children who were formula-fed. The primary difference between the two sources of nourishment is sialic acid, with breast milk containing >4 times that of formula. The mechanism of GMP's therapeutic effects is not known but may involve increased polysialylation (PSA) of neural cell-adhesion molecule (NCAM), increased levels of the neuroprotective GM1 ganglioside, or both. In the present application we will determine whether an over-the-counter (OTC) source of endogenous GMP will have the same therapeutic benefits in 5xFAD transgenics as exogenous GMP incorporated into their chow. Specifically, we will feed mice whey protein isolate (WPI) containing 18% GMP (WPI+GMP) or WPI lacking GMP (WPI-GMP) in their drinking water. The concentration of sialic acid in WPI+GMP is more than eight times higher than that found in mature breast milk. We expect that transgenics receiving WPI+GMP will have better memory, normalized social behavior, and reduced Aβ and associated neuropathology, compared to controls. Importantly, we expect that GMP will have disease-modifying as well as cognitive-enhancing effects. We have shown that manipulations that increase GM1 ganglioside reduce plaque and prevent ongoing neurodegeneration even in aged 5xFAD mice. This is unusual given that current therapies for Alzheimer's disease are only effective when started early. At the end of the study we expect to show that a currently- available OTC product can improve behaviors and attenuate or prevent Alzheimer-related neuropathology.

对记忆的有效评估也许是创作小说最重要的组成部分